Bioventus
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-86.1152.28
Price/Sales ratio
0.750.71
Earnings per Share (EPS)
$-0.08$0.14

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-82.83-31.32-60.80-666.02-87.53159.3366.5190.01-0.75-2.11-0.44-87.53
Price/Sales ratio
4.394.213.973.733.343.203.392.000.310.640.123.20
Price/Book Value ratio
6.025.55N/AN/A7.357.637.671.880.501.900.217.63
Price/Cash Flow ratio
70.7256.47N/AN/A23.6426.8115.2037.53-11.8321.516.5626.81
Price/Free Cash Flow ratio
-186.7793.09N/AN/A27.3133.7221.3555.23-6.3941.3624.5533.72
Price/Earnings Growth ratio
1.94-0.181.277.31-0.13-1.68-0.080.830.000.070.00-0.13
Dividend Yield
0.22%0.09%N/AN/A0.73%0.83%1.82%0.04%N/AN/AN/A0.83%
Profitability Indicator Ratios
Gross Profit Margin
69.28%70.69%66.70%68.46%73.62%73.26%72.71%70.25%64.64%64.05%65.78%73.26%
Operating Profit Margin
0.00%-6.53%5.42%9.25%7.99%9.17%6.61%4.11%-6.96%-15.95%-6.99%9.17%
Pretax Profit Margin
-4.67%-12.60%-2.05%2.96%1.91%2.84%4.95%1.76%-51.53%-23.63%-46.85%2.84%
Net Profit Margin
-5.31%-13.44%-6.54%-0.56%-3.82%2.01%5.10%2.22%-41.66%-30.49%-28.90%2.01%
Effective Tax Rate
-13.62%-6.69%-19.29%-9.06%27.24%16.26%7.49%-25.80%19.13%-0.07%17.60%17.60%
Return on Assets
-2.99%-6.99%N/AN/A-2.75%1.45%3.31%0.78%-15.54%-19.26%-11.26%1.45%
Return On Equity
-7.26%-17.73%N/AN/A-8.40%4.79%11.53%2.08%-67.40%-89.99%-39.76%4.79%
Return on Capital Employed
0.00%-4.15%N/AN/A6.75%8.13%5.71%1.69%-3.33%-12.86%-3.50%8.13%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.89N/A
Quick Ratio
1.310.73N/AN/A1.841.741.491.110.611.000.551.74
Cash ratio
0.300.05N/AN/A0.650.720.700.240.100.210.100.72
Days of Sales Outstanding
70.7478.44N/AN/A82.9891.34100.33105.9297.3387.6593.1982.98
Days of Inventory outstanding
130.49172.71N/AN/A118.80109.68121.27175.64172.19181.02170.23118.80
Operating Cycle
201.23251.15N/AN/A201.79201.03221.60281.56269.52268.68193.21201.03
Days of Payables Outstanding
26.3341.08N/AN/A35.5925.8418.4148.1673.9845.6674.8435.59
Cash Conversion Cycle
174.89210.07N/AN/A166.20175.18203.19233.40195.54223.0260.33175.18
Debt Ratios
Debt Ratio
0.390.39N/AN/A0.440.420.380.290.300.480.750.44
Debt Equity Ratio
0.951.00N/AN/A1.341.391.320.771.322.273.261.34
Long-term Debt to Capitalization
0.470.45N/AN/A0.560.560.540.420.540.670.540.56
Total Debt to Capitalization
0.480.50N/AN/A0.570.580.560.430.560.690.560.58
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.90N/A
Cash Flow to Debt Ratio
0.080.09N/AN/A0.230.200.380.06-0.030.030.020.20
Company Equity Multiplier
2.422.53N/AN/A3.043.303.472.674.334.674.333.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.060.07N/AN/A0.140.110.220.05-0.020.020.010.11
Free Cash Flow / Operating Cash Flow Ratio
-0.370.60N/AN/A0.860.790.710.671.850.520.260.79
Cash Flow Coverage Ratio
0.080.09N/AN/A0.230.200.380.06-0.030.030.020.20
Short Term Coverage Ratio
2.100.51N/AN/A8.603.434.781.27-0.400.550.313.43
Dividend Payout Ratio
-18.59%-2.97%N/AN/A-64.27%133.36%121.17%3.82%N/AN/AN/A-64.27%